Phytanic acid and its metabolite pristanic acid are important branched chain fatty acids (BCFA), which display multiple positive health effects. However, humans can so far only obtain them through the consumption of dairy products, ruminant animal fats or certain fish. It’s not only humans, but mammalian cells in general that require these compounds and they are e.g. routinely used for induction of adipogenic differentiation in bovine precursors in cultured meat production.
acib’s concept is to use an enzymatic cascade for phytanic acid production starting from inexpensive chlorophyll. To find the best enzymes we use a DNA library of the rumen microbiome, where this conversion is performed with exceptional efficiency. Biotechnologically produced phytanic acid can be used as i) human food supplement, ii) supplement for alternative meat and dairy products, iii) growth supplement and differentiation agent for cultured animal cells.
Experts:Dr. Anita Emmerstorfer-Augustin, Dr. Aleksandra Fuchs
Investments, Joint Research Projects, Contract Research
Development status:Technology Readiness Level 2 (Technology concept formulated)
IPR:Can be generated for our industrial partners / investors
Keywords:Enzymatic Conversion, Phytanic Acid, Pristanic Acid, Branched Chained Fatty Acids (BFCA), Health, Anti-diabetic, Anti-cancerogenic, Adipogenic Differentiation, Cultured meat
Picture credits: Pixabay